| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DBTX | Decibel Therapeutics, Inc. | Reid Laurence | President and Chief Executive | Sep 15, 2021 | Buy | $7.64 | 10,000 | 76,400 | 25,849 | Sep 17, 2021, 09:48 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Dec 31, 2014 | Option Exercise | $97.00 | 2,802 | 271,794 | 18,103 | Jan 05, 2015, 05:10 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Dec 31, 2014 | Option Exercise | $15.99 | 17,000 | 271,830 | 20,905 | Jan 05, 2015, 05:10 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Nov 18, 2014 | Option Exercise | $11.12 | 10,000 | 111,227 | 13,905 | Nov 19, 2014, 06:12 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Nov 18, 2014 | Sale | $90.67 | 10,000 | 906,670 | 8,492 | Nov 19, 2014, 06:12 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Aug 18, 2014 | Option Exercise | $8.76 | 13,500 | 118,290 | 17,405 | Aug 20, 2014, 06:45 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Aug 18, 2014 | Sale | $67.34 | 13,500 | 909,030 | 10,905 | Aug 20, 2014, 06:45 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | May 19, 2014 | Sale | $57.83 | 13,500 | 780,684 | 14,805 | May 21, 2014, 04:32 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | May 19, 2014 | Option Exercise | $8.76 | 13,500 | 118,290 | 17,405 | May 21, 2014, 04:32 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Feb 19, 2014 | Option Exercise | $9.40 | 13,500 | 126,965 | 24,305 | Feb 20, 2014, 05:00 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Feb 19, 2014 | Sale | $80.06 | 20,400 | 1,633,240 | 21,226 | Feb 20, 2014, 05:00 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Jan 23, 2014 | Option Exercise | $89.49 | 3,698 | 330,934 | 10,805 | Jan 27, 2014, 04:35 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Dec 30, 2013 | Option Exercise | $64.51 | 930 | 59,994 | 14,503 | Jan 02, 2014, 05:36 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Dec 30, 2013 | Option Exercise | $15.99 | 3,752 | 59,994 | 15,433 | Jan 02, 2014, 05:36 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Nov 13, 2013 | Option Exercise | $15.99 | 13,500 | 215,865 | 25,181 | Nov 15, 2013, 04:53 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Nov 13, 2013 | Sale | $53.36 | 13,500 | 720,302 | 11,681 | Nov 15, 2013, 04:53 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP and Chief Business Officer | May 28, 2013 | Option Exercise | $7.10 | 5,000 | 35,500 | 16,681 | May 30, 2013, 06:17 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP and Chief Business Officer | May 28, 2013 | Sale | $30.00 | 5,000 | 150,000 | 11,681 | May 30, 2013, 06:17 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Feb 08, 2013 | Sale | $25.00 | 5,000 | 125,000 | 11,681 | Feb 12, 2013, 05:44 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Feb 08, 2013 | Option Exercise | $7.10 | 5,000 | 35,500 | 16,681 | Feb 12, 2013, 05:44 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Reid Laurence | SVP, Chief Business Officer | Feb 21, 2012 | Buy | $10.75 | 930 | 9,998 | 11,681 | Feb 23, 2012, 05:00 PM |
Menu